Cargando…
Tobacco Company Efforts to Influence the Food and Drug Administration-Commissioned Institute of Medicine Report Clearing the Smoke: An Analysis of Documents Released through Litigation
BACKGROUND: Spurred by the creation of potential modified risk tobacco products, the US Food and Drug Administration (FDA) commissioned the Institute of Medicine (IOM) to assess the science base for tobacco “harm reduction,” leading to the 2001 IOM report Clearing the Smoke. The objective of this st...
Autores principales: | Tan, Crystal E., Kyriss, Thomas, Glantz, Stanton A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665841/ https://www.ncbi.nlm.nih.gov/pubmed/23723740 http://dx.doi.org/10.1371/journal.pmed.1001450 |
Ejemplares similares
-
The Toxic Effects of Cigarette Additives. Philip Morris' Project Mix Reconsidered: An Analysis of Documents Released through Litigation
por: Wertz, Marcia S., et al.
Publicado: (2011) -
Scientific Evidence for the Addictiveness of Tobacco and Smoking Cessation in Tobacco Litigation
por: Roh, Sungwon
Publicado: (2018) -
Direct disease-inducing effects of menthol through the eyes of tobacco companies
por: Salgado, M Victoria, et al.
Publicado: (2011) -
‘To quarterback behind the scenes, third-party efforts’: the tobacco industry and the Tea Party
por: Fallin, Amanda, et al.
Publicado: (2014) -
How to combat efforts to overturn bans on electronic nicotine delivery systems: lessons from tobacco industry efforts during the 1980s to open closed cigarette markets in Thailand
por: Patanavanich, Roengrudee, et al.
Publicado: (2021)